NPI registry status
Active
2026 NPPES data Dermatopathology (Pathology) Physician NPI 1437316676 M.D.
Verify on CMS → Alyssa Findley, M.D.
Dermatopathology (Pathology) Physician in Riverside, Rhode Island.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 569 in Dermatopathology (Pathology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
227
Medicare Part D claims · 122 beneficiaries · Dermatopathology (Pathology) Physician avg: 434
MIPS score
97.5/100
▲ 14 pts above national avg 83.5 · Exceptional
Industry payments
$24.04
1 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Alyssa Findley, M.D. reported a CMS MIPS final score of 97.5/100 - above the 83.5 national average - and filed 227 Medicare Part D claims in 2024.
- 97.5/100
- MIPS score · +14 vs avg
- 227
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥84th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Alyssa Findley, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1437316676), first enumerated 05/16/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 227 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 97.5/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$24.04 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1437316676 · Dermatopathology (Pathology) Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-ELITE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1437316676
- ENUM-MID 2008
- TAX-NARROW 569
- MIPS-ELITE 97.5/100
- RX-LIGHT 227
- BOOK-THIN 3 in Rhode Island
- PHOTO-FINISH Luis Flores, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Zendee Rose Elab…
Zendee Rose Elaba, MD
97 MIPS pts
- Scott Wickless, …
Scott Wickless, DO
97.4 MIPS pts
- Findley · this p…
Findley · this provider
97.5 MIPS pts
- Luis Flores, MD …
Luis Flores, MD
97.5 MIPS pts
- James Lyons, M.D…
James Lyons, M.D.
97.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Alyssa Findley, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
98 ≥ 84th percentile 84% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Alyssa Findley, M.D. sits
This provider among dermatopathology (pathology) physician peers
Across the 21 dermatopathology (pathology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Alyssa Findley, M.D. writes more Part D claims than 48% of them and scores higher on MIPS quality than 71% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one dermatopathology (pathology) physician peer from a representative sample of 20; the gold marker is Alyssa Findley, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Alyssa Findley, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Alyssa Findley, M.D.?
High performer (top quartile)Primary specialty
Dermatopathology (Pathology) Physician
Medicare Part D claims
227 48% vs specialty avg
MIPS final score
97.5/100 14 pts vs avg
Specialty distribution in Rhode Island
How Dermatopathology (Pathology) Physician compares to other specialties among Rhode Island providers
Medicare quality performance, MIPS
Alyssa Findley, M.D.'s 2023 MIPS final score plotted against the Dermatopathology (Pathology) Physician national average
- MIPS Final Score
- 97.5/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1437316676 |
|---|---|
| Specialty | Dermatopathology (Pathology) Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 05/16/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
97.5
Final Score
Measured-score avg: 83.5
95
Quality
Reporting: Individual
Hospital and facility affiliations
Facilities where Alyssa Findley, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Findley Dermatology, LLC
East Providence, RI
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Alyssa Findley, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$24
Largest payer
Ortho Dermatologics, a division of Bausch Health US, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
227
Total Claims
$5K
Total Drug Cost
122
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 242.533
- Total Day Supply
- 4,646
- Generic Drug Cost
- $5K
- Antibiotic Claims
- 72
Patient Demographics
- Average Patient Age
- 76.5 years
- Avg HCC Risk Score
- 1.04
- Gender Split
- 56% female / 44% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Alyssa Findley, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Mupirocin
Mupirocin
49 claims
- Doxycycline Hyclate
Doxycycline Hyclate
38 claims
- Cephalexin
Cephalexin
31 claims
- Clobetasol Propion…
Clobetasol Propionate
21 claims
- Ketoconazole 15
Ketoconazole
15 claims
- Triamcinolone Acet… 13
Triamcinolone Acetonide
13 claims
| Drug | Claims |
|---|---|
| Mupirocin | 49 |
| Doxycycline Hyclate | 38 |
| Cephalexin | 31 |
| Clobetasol Propionate | 21 |
| Ketoconazole | 15 |
| Triamcinolone Acetonide | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Dermatopathology (Pathology) Physician in RI →
All providers in Rhode Island →
Compare specialties →
Dermatopathology (Pathology) Physician Overview
How Alyssa Findley, M.D. fits within the Dermatopathology (Pathology) Physician landscape nationally.
569
Dermatopathology (Pathology) Physician Providers in US
49
States with Dermatopathology (Pathology) Physician
434
Avg Claims per Provider
Alyssa Findley, M.D.'s 227 claims are below the specialty average of 434.
Nationwide Dermatopathology (Pathology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Findley, both outside Rhode Island so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (97.5 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Dermatopathology (Pathology) Physician Providers in Rhode Island
Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as Findley.
One of 3 Dermatopathology (Pathology) Physician providers enrolled in Rhode Island, 2 are shown here.
Compare Dermatopathology (Pathology) Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Alyssa Findley, M.D.'s specialty? ▼
Alyssa Findley, M.D. specializes in Dermatopathology (Pathology) Physician and practices in Riverside, Rhode Island. Credentials: M.D..
How much does Alyssa Findley, M.D. prescribe under Medicare Part D? ▼
In 2024, Alyssa Findley, M.D. wrote 227 Medicare Part D claims totaling $5K in drug costs for 122 beneficiaries.
What is Alyssa Findley, M.D.'s Medicare quality score? ▼
Alyssa Findley, M.D. has a CMS MIPS Final Score of 97.5/100 (Quality: 95). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Alyssa Findley, M.D. located? ▼
Alyssa Findley, M.D. is located at 1275 WAMPANOAG TRL UNIT 6, Riverside, RI, 02915. Phone: (401) 415-8586.
What is Alyssa Findley, M.D.'s NPI number? ▼
Alyssa Findley, M.D.'s National Provider Identifier (NPI) is 1437316676, issued on 05/16/2008.
How many Dermatopathology (Pathology) Physician providers are there in the US? ▼
There are 569 Dermatopathology (Pathology) Physician providers across 49 states in the US. The average Dermatopathology (Pathology) Physician provider writes 434 Medicare Part D claims per year.
What drugs does Alyssa Findley, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Alyssa Findley, M.D.'s most frequently prescribed drugs include Mupirocin, Doxycycline Hyclate, Cephalexin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Alyssa Findley, M.D. accept Medicare? ▼
Alyssa Findley, M.D. appears in CMS Medicare data with 227 Part D claims and 122 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Alyssa Findley, M.D.'s credentials? ▼
Alyssa Findley, M.D.'s NPI is 1437316676 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.